Inovio Pharmaceuticals, Inc. (INO)
1.435
-0.02
(-1.71%)
USD |
NASDAQ |
Nov 13, 16:00
1.42
-0.02
(-1.05%)
After-Hours: 19:59
Inovio Pharmaceuticals Debt to Equity Ratio : -0.2147 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.2147 |
| June 30, 2026 | 1.831 |
| March 31, 2026 | 1.433 |
| December 31, 2025 | 0.3888 |
| September 30, 2025 | -1.298 |
| June 30, 2025 | 0.3736 |
| March 31, 2025 | 0.2199 |
| December 31, 2024 | 0.1732 |
| September 30, 2024 | 0.1692 |
| June 30, 2024 | 0.1342 |
| March 31, 2024 | 0.1422 |
| December 31, 2023 | 0.2574 |
| September 30, 2023 | 0.2157 |
| June 30, 2023 | 0.1816 |
| March 31, 2023 | 0.1564 |
| December 31, 2022 | 0.1442 |
| September 30, 2022 | 0.1216 |
| June 30, 2022 | 0.1119 |
| March 31, 2022 | 0.0948 |
| December 31, 2021 | 0.0826 |
| September 30, 2021 | 0.0731 |
| June 30, 2021 | 0.0665 |
| March 31, 2021 | 0.0583 |
| December 31, 2020 | 0.0847 |
| September 30, 2020 | 0.2304 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.5424 |
| March 31, 2020 | 0.5345 |
| December 31, 2019 | 28.97 |
| September 30, 2019 | 2.761 |
| June 30, 2019 | 1.608 |
| March 31, 2019 | 1.084 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Precigen, Inc. | 1.177 |
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Ionis Pharmaceuticals, Inc. | 5.520 |
| Nektar Therapeutics | 0.1505 |
| Rigel Pharmaceuticals, Inc. | 0.0175 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 60.14M |
| Total Liabilities (Quarterly) | 94.06M |
| Shareholders Equity (Quarterly) | -33.92M |
| Current Ratio | 0.575 |
| Net Debt Paydown Yield | 0.50% |